RxSight, Inc. RXST Rxlal — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by RxSight, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about RxSight, Inc.'s rxlal — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is RxSight, Inc.'s rxlal — revenue?
- RxSight, Inc. (RXST) reported rxlal — revenue of $27.04M in Q1 2026.
- How has RxSight, Inc.'s rxlal — revenue changed year-over-year?
- RxSight, Inc.'s rxlal — revenue decreased by 0.5% year-over-year, from $27.19M to $27.04M.
- What is the long-term trend for RxSight, Inc.'s rxlal — revenue?
- Over 3 years (2022 to 2025), RxSight, Inc.'s rxlal — revenue has grown at a 63.0% compound annual growth rate (CAGR), from $24.97M to $108.06M.
- What does rxlal — revenue mean?
- This metric represents the total net sales generated from the sale of light adjustable lenses and associated capital equipment, excluding any assessed taxes. It serves as a primary indicator of market adoption and commercial traction for the company's core ophthalmic technology segment. Growth in this figure reflects the successful expansion of the installed base and the recurring demand for specialized intraocular lens products.